Cleared Traditional

K770311 - GLUCOSE REAGENT

K770311 is the FDA 510(k) clearance for GLUCOSE REAGENT by Icn Pharmaceuticals, Inc.. It is a Class 2 Chemistry device (product code CFR) cleared through the Traditional 510(k) pathway after a 42-day FDA review.

K770311 · Icn Pharmaceuticals, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1977
Decision
42d
Days
Class 2
Risk

K770311 is an FDA 510(k) clearance for the GLUCOSE REAGENT, ENZYMATIC. Classified as Hexokinase, Glucose (product code CFR), Class II - Special Controls.

Submitted by Icn Pharmaceuticals, Inc. (Orangeburg, US). The FDA issued a Cleared decision on March 30, 1977 after a review of 42 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Icn Pharmaceuticals, Inc. devices

Submission Details

510(k) Number K770311 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 16, 1977
Decision Date March 30, 1977
Days to Decision 42 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
46d faster than avg
Panel avg: 88d · This submission: 42d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CFR Hexokinase, Glucose
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CFR Hexokinase, Glucose

All 84
Devices cleared under the same product code (CFR) and FDA review panel - the closest regulatory comparables to K770311.
GLUCOSE REAGENT (HEXOHINASE)
K771311 · Mallinckrodt Critical Care · Aug 1977
FLUCOSE U.V. TEST KIT
K770844 · Mallinckrodt Critical Care · Jul 1977
AUTO-ENZYMATIC GLUCOSE FOR ANALYZER
K770886 · Harleco · Jul 1977
AUTO-ENZYMATIC GLUCOSE
K770229 · Harleco · Mar 1977
GLUCOSE (HEXOKINASE) DELTA TEST ASSAY
K770262 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Feb 1977
AUTO-ENZYMATIC GLUCOSE
K761240 · Harleco · Dec 1976